sTn also inhibits the recognition of cancer cells by the immune cells by preventing the mutual recognition of cell–cell or cell–matrix substances, such as selectins, siglecs, and galectins, thereby protecting the invasion and metastasis ability of tumor cells. The gene discussed is EEF1A2; the disease is cancer.